Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis

Dominique Bozec1,2, Alina C Iuga3, Giulia Roda4,5

  • 1Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Oncotarget
|June 27, 2016
PubMed

Insights

Receptor interacting protein kinase 3 (RIPK3) suppresses colorectal cancer (CRC) by controlling inflammation and cell proliferation. Loss of RIPK3 promotes tumor growth, highlighting its role as a colon tumor suppressor.

Area of Science:

  • Cell Biology
  • Immunology
  • Oncology

Background:

  • Necroptosis, a programmed cell death, is regulated by receptor interacting protein kinase 3 (RIPK3).
  • In vitro studies suggest RIPK3-deficient cancer cells are invasive, but its in vivo role in cancer remains unclear.

Purpose of the Study:

  • To investigate the physiological role of RIPK3 in colorectal cancer (CRC) development.
  • To determine if RIPK3 functions as a tumor suppressor in the intestine.

Main Methods:

  • Utilized RIPK3-deficient mice to study colitis-associated CRC.
  • Analyzed inflammatory mediators, tumor-promoting factors, and key signaling pathways (NF-κB, STAT3, AKT, Wnt-β-catenin).
  • Examined RIPK3 expression in human inflammatory bowel disease and CRC patient tumors.

Main Results:

  • RIPK3-deficient mice showed increased susceptibility to colitis-associated CRC with elevated pro-inflammatory and tumor-promoting factors.
  • Tumorigenesis in RIPK3-deficient mice was driven by uncontrolled NF-κB, STAT3, AKT, and Wnt-β-catenin signaling, promoting aberrant intestinal epithelial cell proliferation.
  • RIPK3 expression was reduced in human inflammatory bowel disease and CRC tumors, correlating with cancer progression.

Conclusions:

  • RIPK3 plays a critical role in suppressing colorectal cancer.
  • RIPK3 exhibits anti-inflammatory and anti-tumoral functions in the intestine.
  • RIPK3 is identified as a novel colon tumor suppressor, crucial for preventing CRC development.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K